The 22 analysts offering 12-month price forecasts for Elevance Health Inc have a median target of 552.50, with a high estimate of 625.00 and a low estimate of 335.00. The median estimate represents a +16.33% increase from the last price of 474.94.
The current consensus among 25 polled investment analysts is to Buy stock in Elevance Health Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $7.13
Reporting Date Nov 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.